Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS - Metabolomics data for Matrix pipeline validation QE data Low biomass samples

ABSTRACT: Metabolomics data collected for low biomass skin and environment samples on quadrupole-Orbitrap mass spectrometer to validate a standardized method for sample accession, DNA and metabolite extraction using single tubes (Matrix tubes).

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Na

SUBMITTER: Pieter C. Dorrestein

PROVIDER: MSV000098650 | GNPS | Sun Jul 27 07:15:00 BST 2025

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Metabolomics data for Matrix pipeline validation QE data High biomass samples

Project description:Metabolomics data collected for high biomass fecal and saliva samples on quadrupole-Orbitrap mass spectrometer to validate a standardized method for sample accession, DNA and metabolite extraction using single tubes (Matrix tubes).

2022-10-17 | MSV000090544 | MassIVE

GNPS - Metabolomics data for Matrix pipeline validation QE data High biomass samples

2022-10-17 | MSV000090544 | GNPS

Metabolomics data for Matrix pipeline validation

Project description:Metabolomics data for validation of the matrix pipeline.

2022-08-04 | MSV000090083 | MassIVE

GNPS - Metabolomics data for Matrix pipeline validation

Project description:Metabolomics data for validation of the matrix pipeline.

2022-08-04 | MSV000090083 | GNPS

Castanet pipeline validation study

Project description:Castanet pipeline validation study

| PRJEB77004 | ENA

Implementing an X-ray validation pipeline for the Protein Data Bank.

Project description:There is an increasing realisation that the quality of the biomacromolecular structures deposited in the Protein Data Bank (PDB) archive needs to be assessed critically using established and powerful validation methods. The Worldwide Protein Data Bank (wwPDB) organization has convened several Validation Task Forces (VTFs) to advise on the methods and standards that should be used to validate all of the entries already in the PDB as well as all structures that will be deposited in the future. The recommendations of the X-ray VTF are currently being implemented in a software pipeline. Here, ongoing work on this pipeline is briefly described as well as ways in which validation-related information could be presented to users of structural data.

| S-EPMC3322607 | biostudies-literature

An Open-Source QIIME2 and R Pipeline for Multi-Amplicon 16S rRNA Profiling: Validation and Application in Pediatric Microbiome Studies

Project description:This study presents a validated, open-source QIIME2- and R-based pipeline for 16S rRNA gene profiling using multi-amplicon sequencing. It aims to overcome the limitations of commercial, closed-source tools by offering a standardized and reproducible workflow. The pipeline was benchmarked against proprietary software using five mock communities and 12 child–caregiver fecal sample pairs, showing nearly identical microbial profiles, greater sequencing depth, and improved taxonomic resolution. High reproducibility (R = 0.99, p < 0.0001) was achieved across all datasets. Application to pediatric cancer samples revealed distinct Bifidobacterium variants in children whose microbiota closely matched their caregivers’. This highlights the pipeline’s utility in studying microbial relationships. Overall, the pipeline supports transparent, adaptable, and accurate microbiome analysis, advancing research in both clinical and experimental settings while promoting open-source solutions for reproducible science.

2025-07-14 | GSE300047 | GEO

Enhanced validation of antibodies for research applications

Project description:There is a need for standardized validation methods for antibody specificity and selectivity. Recently, five alternative validation “pillars" were proposed to explore the specificity of research antibodies using methods with no need for prior knowledge about the protein target. Here, we show that these principles can be used in a streamlined manner for enhanced validation of research antibodies in Western blot applications. More than 6,000 antibodies were validated with at least one of these strategies involving orthogonal methods, genetic knockdown, recombinant expression, independent antibodies and migration capture mass spectrometry analysis. The results show a path forward for efforts to validate antibodies in an application-specific manner suitable for both providers and users.

2018-08-21 | PXD010178 | Pride

Chondrosarcoma Validation Study

Project description:Agilent whole exome hybridisation capture was performed on genomic DNA derived from Chondrosarcoma cancer and matched normal DNA from the same patients. Next Generation sequencing performed on the resulting exome libraries and mapped to build 37 of the human reference genome to facilitate the identification of novel cancer genes. Now we aim to re find and validate the findings of those exome libraries using bespoke pulldown methods and sequencing the products.

2016-05-17 | E-ERAD-37 | biostudies-arrayexpress

Analysis of tumor DNA markers in the plasma of colorectal cancer patients by liquid biopsy

Project description:Interventions: Group 1: Blood and sputum samples as well as paraffin embedded tumour tissue from patients with microsatellite stable colorectal cancer shall be analysed before therapy and over time to establish and validate hotspot mutation and somatic copy number variant (SCNAs) analysis. We therefore need the following samples: - Two Cell-Free DNA BCT CE Streck tubes with 8 ml blood per sampling for preparation of plasma-DNA. - One sputum tube (only at study inclusion). - FFPE tissue samples from the primary tumor (from initial surgery) Group 2: Blood samples of tumor-free control persons shall be tested for hotspot mutations and somatic copy number variants (SCNAs) to identify technical artefacts and improve our protocols. We therefore need the following samples: - Two Cell-Free DNA BCT CE Streck tubes with 8 ml blood per sampling for preparation of plasma-DNA. Primary outcome(s): Identification of tumorspecific SCNAs in plasma samples of colorectal cancer patients Study Design: Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: other

| 2433407 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data